GH
Guardant Health, Inc.Company with tickers: GH
CIK
1576280
CUSIP
40131M109
Shares Outstanding
132,599,929
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $301,665,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Revenue (ASC 606) | $301,665,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $91,038,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-121,350,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-112,075,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.85 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.85 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |